Vaxcyte Announces Closing of $862.5 Million Public Offering

03.02.2024 - SAN CARLOS, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) - Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today the ...

Related Keywords

Boston , Massachusetts , United States , New York , Charlotte , North Carolina , Janet Graesser , Jennifer Zibuda , Sutro Biopharma Inc , Evercore Group , Prospectus Department , Groupa Strep , Equity Syndicate Department , Leerink Partners , Exchange Commission , Vaxcyte Inc , Corporate Communications , Syndicate Department , Bofa Securities , Tryon Street , Equity Capital Markets , Sutro Biopharma , Vice President , Senior Director , Vaxcyte Chart , Axcyte Kurs , Axcyte Aktie ,